This inventor holds 2 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Northeastern University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,273 
1 out of 693 
Years Active: 2023-2026
Title: Wei Li - Innovator in Breast Cancer Research
Introduction
Wei Li is a prominent inventor based in Boston, MA, who has made significant contributions to the field of breast cancer research. His work focuses on identifying novel biomarkers that can predict endocrine resistance in breast cancer, which is crucial for improving treatment outcomes for patients.
Latest Patents
Wei Li holds a patent for his invention titled "Biomarkers predictive of endocrine resistance in breast cancer." This patent is based on the identification of biomarkers that can help in predicting how patients will respond to endocrine therapy, thereby aiding in personalized treatment strategies.
Career Highlights
Wei Li is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts his research. His work has been instrumental in advancing the understanding of breast cancer and its treatment.
Collaborations
Wei Li collaborates with esteemed colleagues, including Xiaole Liu and Myles Brown, who share his commitment to improving breast cancer therapies through innovative research.
Conclusion
Wei Li's contributions to breast cancer research through his innovative patent and collaborations highlight his dedication to advancing medical science. His work is vital for developing more effective treatment options for patients facing this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile